These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33737099)

  • 1. Current advances and challenges of mesenchymal stem cells-based drug delivery system and their improvements.
    Su Y; Zhang T; Huang T; Gao J
    Int J Pharm; 2021 May; 600():120477. PubMed ID: 33737099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Drug Delivery System Using Mesenchymal Stem Cells and Membrane-Coated Nanoparticles.
    Joshi S; Allabun S; Ojo S; Alqahtani MS; Shukla PK; Abbas M; Wechtaisong C; Almohiy HM
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells: A living carrier for active tumor-targeted delivery.
    Zhang T; Lin R; Wu H; Jiang X; Gao J
    Adv Drug Deliv Rev; 2022 Jun; 185():114300. PubMed ID: 35447165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic.
    Wu HH; Zhou Y; Tabata Y; Gao JQ
    J Control Release; 2019 Jan; 294():102-113. PubMed ID: 30553849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off-the-shelf versatile tumor delivery vehicle.
    Taheri M; Tehrani HA; Dehghani S; Alibolandi M; Arefian E; Ramezani M
    Med Res Rev; 2024 Jul; 44(4):1596-1661. PubMed ID: 38299924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic drug delivery platforms based on mesenchymal stem cells impregnated with light-responsive submicron sized carriers.
    Muslimov AR; Timin AS; Bichaykina VR; Peltek OO; Karpov TE; Dubavik A; Nominé A; Ghanbaja J; Sukhorukov GB; Zyuzin MV
    Biomater Sci; 2020 Feb; 8(4):1137-1147. PubMed ID: 31584052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds.
    Cantore S; Crincoli V; Boccaccio A; Uva AE; Fiorentino M; Monno G; Bollero P; Derla C; Fabiano F; Ballini A; Santacroce L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(5):466-469. PubMed ID: 29692270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of mesenchymal stem cells in antineoplastic drugs delivery for tumor-targeted therapy].
    Wang X; Ouyang X; Sun X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):525-533. PubMed ID: 30693696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
    Layek B; Sadhukha T; Panyam J; Prabha S
    Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles.
    Gao Z; Zhang L; Hu J; Sun Y
    Nanomedicine; 2013 Feb; 9(2):174-84. PubMed ID: 22772046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and local delivery of mesenchymal stem cells for heart renovation: Challenges and innovations.
    Liu Z; Mikrani R; Zubair HM; Taleb A; Naveed M; Baig MMFA; Zhang Q; Li C; Habib M; Cui X; Sembatya KR; Lei H; Zhou X
    Eur J Pharmacol; 2020 Jun; 876():173049. PubMed ID: 32142771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances and clinical challenges of mesenchymal stem cell therapy.
    Mei R; Wan Z; Yang C; Shen X; Wang R; Zhang H; Yang R; Li J; Song Y; Su H
    Front Immunol; 2024; 15():1421854. PubMed ID: 39100671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual delivery of encapsulated BM-MSCs and BMP-2 improves osteogenic differentiation and new bone formation.
    Kong Y; Zhao Y; Li D; Shen H; Yan M
    J Biomed Mater Res A; 2019 Oct; 107(10):2282-2295. PubMed ID: 31152570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
    Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
    FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives in Engineered Mesenchymal Stem/Stromal Cells Based Anti- Cancer Drug Delivery Systems.
    Ackova DG; Kanjevac T; Rimondini L; Bosnakovski D
    Recent Pat Anticancer Drug Discov; 2016; 11(1):98-111. PubMed ID: 26554397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress on utilizing mesenchymal stem cells as cellular delivery system for targeting delivery of as drug/gene for anti-tumor therapy].
    Li A; Zhang T; Gao J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(1):20-34. PubMed ID: 32621413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
    Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
    Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cells and Cancer: Clinical Challenges and Opportunities.
    Lin W; Huang L; Li Y; Fang B; Li G; Chen L; Xu L
    Biomed Res Int; 2019; 2019():2820853. PubMed ID: 31205939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic mesenchymal stem cell sheet therapy: A new frontier in drug delivery systems.
    Kim K; Bou-Ghannam S; Kameishi S; Oka M; Grainger DW; Okano T
    J Control Release; 2021 Feb; 330():696-704. PubMed ID: 33347942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological Cells as Therapeutic Delivery Vehicles.
    Bush LM; Healy CP; Javdan SB; Emmons JC; Deans TL
    Trends Pharmacol Sci; 2021 Feb; 42(2):106-118. PubMed ID: 33342562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.